These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diet and growth of children with glycogen storage disease Types I and III. Daeschel IE, Janick LS, Kramish MJ, Coleman RA. J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953 [Abstract] [Full Text] [Related]
3. [Treatment of glycogenosis type III with total parenteral nutrition, continuous intragastric infusion and D-thyroxine]. Böhles H, Dick W, Scharf J. Infusionsther Klin Ernahr; 1982 Aug; 9(4):160-1. PubMed ID: 6813261 [Abstract] [Full Text] [Related]
4. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease. Greene HL, Slonim AE, O'Neill JA, Burr IM. N Engl J Med; 1976 Feb 19; 294(8):423-5. PubMed ID: 813144 [Abstract] [Full Text] [Related]
5. Glycogen storage disease: long-term follow-up of nocturnal intragastric feeding. Michels VV, Beaudet AL, Potts VE, Montandon CM. Clin Genet; 1982 Feb 19; 21(2):136-40. PubMed ID: 6805987 [Abstract] [Full Text] [Related]
10. Nutritional therapy for glycogen storage diseases. Heller S, Worona L, Consuelo A. J Pediatr Gastroenterol Nutr; 2008 Aug 19; 47 Suppl 1():S15-21. PubMed ID: 18667910 [Abstract] [Full Text] [Related]
11. [Nutritional therapy of glycogen storage disease types I and III]. Moses SW, Phillip M, Bashan N. Harefuah; 1987 Sep 19; 113(5-6):135-7. PubMed ID: 3121476 [No Abstract] [Full Text] [Related]
12. Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins. Fernandes J, Alaupovic P, Wit JM. Pediatr Res; 1989 Apr 19; 25(4):327-31. PubMed ID: 2542871 [Abstract] [Full Text] [Related]
13. Optimal rate of enteral glucose administration in children with glycogen storage disease type I. Schwenk WF, Haymond MW. N Engl J Med; 1986 Mar 13; 314(11):682-5. PubMed ID: 3081806 [Abstract] [Full Text] [Related]
15. [Metabolic disorders of the liver.Part 2: glycogen storage diseases, hereditary fructose intolerance, galactosemia and hepatic porphyrias]. Donner MG, Erhardt A, Häussinger D. Dtsch Med Wochenschr; 2010 Dec 13; 135(50):2540-7. PubMed ID: 21140331 [No Abstract] [Full Text] [Related]
16. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Slonim AE, Weisberg C, Benke P, Evans OB, Burr IM. Ann Neurol; 1982 Apr 13; 11(4):420-2. PubMed ID: 7049057 [Abstract] [Full Text] [Related]
17. Glycogen storage disease type I. Results of treatment with frequent daytime feeding, combined with nocturnal intragastric feeding and with administration of an alpha-glucosidase inhibitor. Gröbe H, Ullrich K. Eur J Pediatr; 1983 Apr 13; 140(2):102-4. PubMed ID: 6411473 [Abstract] [Full Text] [Related]
18. Type I glycogen storage disease: five years of management with nocturnal intragastric feeding. Greene HL, Slonim AE, Burr IM, Moran JR. J Pediatr; 1980 Mar 13; 96(3 Pt 2):590-5. PubMed ID: 6767011 [Abstract] [Full Text] [Related]
19. Glycogen storage disease: effects of glucose infusions on [15N]glycine kinetics and nitrogen metabolism. Yudkoff M, Nissim I, Stanley C, Baker L, Segal S. J Pediatr Gastroenterol Nutr; 1984 Mar 13; 3(1):81-8. PubMed ID: 6582249 [Abstract] [Full Text] [Related]
20. A new feeding device for treatment of glycogen storage disease. Ralstrom CS, O'Riordan M, Krieger I. ASDC J Dent Child; 1987 Mar 13; 54(3):176-8. PubMed ID: 3108340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]